Literature DB >> 7595516

The UDP-galactose:ceramide galactosyltransferase: expression pattern in oligodendrocytes and Schwann cells during myelination and substrate preference for hydroxyceramide.

N Schaeren-Wiemers1, P van der Bijl, M E Schwab.   

Abstract

Galactosylceramide ("galactocerebroside"; GalC) is a major glycolipid in the myelin sheath of the CNS and the PNS. The enzyme UDP-galactose:ceramide galactosyltransferase (CGalT) catalyzes the final step of the synthesis of GalC: the transfer of galactose to ceramide. By a differential screening approach, we have isolated a cDNA, the sequence of which is identical to the recently isolated cDNA clones for CGalT. By nothern analysis and in situ hybridization we demonstrated that CGalT mRNA is expressed at birth in oligodendrocytes and Schwann cells, an expression pattern corresponding to the onset of myelination. In addition to the high expression levels of CGalT in oligodendrocytes and Schwann cells, in situ hybridization also showed expression in subtypes of neurons in spinal cord, cerebellum, and brain-stem in the adult CNS, but at a much lower level than in oligodendrocytes. Expression of CGalT in COS cells demonstrated that CGalT has a preference for hydroxyceramide as a substrate. CGalT-expressing COS cells synthesize and transport GalC to their cell surface as shown by immunofluorescence and by lipid analysis of living cells. Our results suggested that the CGalT specifically uses hydroxyceramide for the synthesis of GalC and that separate (co)enzymes are not needed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7595516     DOI: 10.1046/j.1471-4159.1995.65052267.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  31 in total

1.  Molecular cloning and characterization of galactosylceramide expression factor-1 (GEF-1).

Authors:  Kiyoshi Ogura; Tadashi Tai
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

2.  Drastically abnormal gluco- and galactosylceramide composition does not affect ganglioside metabolism in the brain of mice deficient in galactosylceramide synthase.

Authors:  K Suzuki; M T Vanier; T Coetzee; B Popko
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

3.  Central nervous system dysfunction in a mouse model of FA2H deficiency.

Authors:  Kathleen A Potter; Michael J Kern; George Fullbright; Jacek Bielawski; Steven S Scherer; Sabrina W Yum; Jian J Li; Hua Cheng; Xianlin Han; Jagadish Kummetha Venkata; P Akbar Ali Khan; Bärbel Rohrer; Hiroko Hama
Journal:  Glia       Date:  2011-04-13       Impact factor: 7.452

Review 4.  A microglial hypothesis of globoid cell leukodystrophy pathology.

Authors:  Alexandra M Nicaise; Ernesto R Bongarzone; Stephen J Crocker
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

Review 5.  Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.

Authors:  Je-Seong Won; Avtar K Singh; Inderjit Singh
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

Review 6.  Fatty acid 2-Hydroxylation in mammalian sphingolipid biology.

Authors:  Hiroko Hama
Journal:  Biochim Biophys Acta       Date:  2009-12-21

Review 7.  Multi-system disorders of glycosphingolipid and ganglioside metabolism.

Authors:  You-Hai Xu; Sonya Barnes; Ying Sun; Gregory A Grabowski
Journal:  J Lipid Res       Date:  2010-03-08       Impact factor: 5.922

8.  A mammalian fatty acid hydroxylase responsible for the formation of alpha-hydroxylated galactosylceramide in myelin.

Authors:  Matthias Eckhardt; Afshin Yaghootfam; Simon N Fewou; Inge Zöller; Volkmar Gieselmann
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

9.  Structural analysis of neutral glycosphingolipids from Ascaris suum adults (Nematoda:Ascaridida).

Authors:  G Lochnit; R D Dennis; U Zähringer; R Geyer
Journal:  Glycoconj J       Date:  1997-04       Impact factor: 2.916

Review 10.  Mechanisms and functional features of polarized membrane traffic in epithelial and hepatic cells.

Authors:  M M Zegers; D Hoekstra
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.